Citation map · Study

SZodixStudyAcademic Library

Shelves Open access

Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated

The experimental effects of psilocybin on symptoms of anxiety and depression: A meta-analysis

16 references·16 citing·36 second hopsampled

FromToDepth

this work references cited by second hop· second hop is a sample of the most-cited connections

References

2003Measuring inconsistency in meta-analyses63,086 cited
2009Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement.44,857 cited
2009Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement37,549 cited
2008Cochrane Handbook for Systematic Reviews of Interventions25,045 cited
2010Conducting Meta-Analyses in R with the metafor Package20,412 cited
2009Introduction to Meta‐Analysis14,215 cited
2021Introduction to Meta‐Analysis9,785 cited
1979The file drawer problem and tolerance for null results.9,043 cited
2013Power failure: why small sample size undermines the reliability of neuroscience7,634 cited
2010Cochrane Handbook for Systematic Reviews of Interventions5,176 cited
2005The empirical status of cognitive-behavioral therapy: A review of meta-analyses3,214 cited
2016Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial2,196 cited
2015The Great Psychotherapy Debate1,769 cited
2016Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial1,696 cited

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work

2016Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study1,533 cited

2005THE FILE-DRAWER PROBLEM REVISITED: A GENERAL WEIGHTED METHOD FOR CALCULATING FAIL-SAFE NUMBERS IN META-ANALYSIS1,283 cited

Cited by

2023Psilocybin therapy for females with anorexia nervosa: a phase 1, open-label feasibility study159 cited
2021Molecular Mechanisms of Psilocybin and Implications for the Treatment of Depression127 cited
2020Psilocybin as a New Approach to Treat Depression and Anxiety in the Context of Life-Threatening Diseases—A Systematic Review and Meta-Analysis of Clinical Trials113 cited
2021Registered clinical studies investigating psychedelic drugs for psychiatric disorders97 cited
2021Optimal dosing for psilocybin pharmacotherapy: Considering weight-adjusted and fixed dosing approaches96 cited
2022Diversity, biology, and history of psilocybin-containing fungi: Suggestions for research and technological development94 cited
2021Dose–response relationships of psilocybin-induced subjective experiences in humans93 cited
2024Efficacy of psilocybin for treating symptoms of depression: systematic review and meta-analysis93 cited
2021Psychedelics, Sociality, and Human Evolution86 cited
2020The therapeutic potential of microdosing psychedelics in depression85 cited
2021Associations between lifetime classic psychedelic use and markers of physical health74 cited
2022The therapeutic potential of psilocybin: a systematic review74 cited
2022Psilocybin in neuropsychiatry: a review of its pharmacology, safety, and efficacy73 cited
2020Psychedelic Research and the Need for Transparency: Polishing Alice’s Looking Glass69 cited
2020Post-acute psychological effects of classical serotonergic psychedelics: a systematic review and meta-analysis68 cited
2021Use of psilocybin (“mushrooms”) among US adults: 2015–201864 cited